ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $71,789,000 | +74.4% | 772,423 | +11.8% | 0.02% | +61.5% |
| Q3 2021 | $41,156,000 | +18.0% | 691,112 | +35.1% | 0.01% | +30.0% |
| Q2 2021 | $34,885,000 | +19.6% | 511,497 | +21.7% | 0.01% | +11.1% |
| Q1 2021 | $29,173,000 | -31.9% | 420,414 | -24.6% | 0.01% | -35.7% |
| Q4 2020 | $42,824,000 | +1.0% | 557,382 | -1.7% | 0.01% | -12.5% |
| Q3 2020 | $42,416,000 | +48.2% | 567,134 | +24.8% | 0.02% | +33.3% |
| Q2 2020 | $28,617,000 | +21.0% | 454,598 | -19.3% | 0.01% | 0.0% |
| Q1 2020 | $23,657,000 | +37.7% | 563,255 | +48.9% | 0.01% | +71.4% |
| Q4 2019 | $17,182,000 | +11.3% | 378,279 | +12.1% | 0.01% | +16.7% |
| Q3 2019 | $15,438,000 | -41.9% | 337,302 | -25.5% | 0.01% | -40.0% |
| Q2 2019 | $26,560,000 | – | 453,010 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
| Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
| Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
| Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
| Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
| First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
| SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
| Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
| DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
| Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |